Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 1c, Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rebounds after Fed's first rate hike in years as oil, Treasury yields dip
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- Paradium AI (PAAI) Halted, News Pending
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Hims & Hers Health, Inc. Reports Record Fourth Quarter and Full Year 2022 Financial Results
February 27, 2023 4:15 PM ESTFull year 2022 revenue of $526.9 million, up 94% year-over-year
Q4 2022 record revenue of $167.2 million, up 97% year-over-year
Q4 2022 net loss of $10.9 million and achieves Adjusted EBITDA profitability of $3.9 million
Eclipses one million subscribers at year end, up 88% year-over-year
Provides Q1 and full year 2023 guidance, with full year 2023 revenue in the range of $735 million to $755 million and Adjusted EBITDA in the range of $20 million to $30 million
Introduces 2025 targets of at least $1.2 billion in revenue and $100 million in... More
